The study was interrupted because of development of meningoencephalitis in 6% of immunized patients, but initial data on neuropsychological test battery revealed differences favoring Ab responders (103) suggesting a protective role of Igs against Aβ in AD progression. The gene discussed is CUBN; the disease is Alzheimer disease.